Table 4. Mucosa visibility.
Optimal visibility | |||
Split dose regimen (%) | Full dose regimen (%) | P value | |
ITT population | |||
|
60 | 50.8 | 0.07 |
|
65.6 | 43.5 | 0.01 |
ITT, intention-to-treat.
Optimal visibility | |||
Split dose regimen (%) | Full dose regimen (%) | P value | |
ITT population | |||
|
60 | 50.8 | 0.07 |
|
65.6 | 43.5 | 0.01 |
ITT, intention-to-treat.